Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CereFlow™ V1.2

K-Number: K211059 · 2023-03-31

Decision Date2023-03-31
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

CereFlow™ V1.2 is a medical device manufactured by Translational Mri, LLC. It received FDA 510(k) clearance on 2023-03-31 under approval number K211059. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CereFlow™ V1.2?

CereFlow™ V1.2 is a medical device that received FDA 510(k) clearance on 2023-03-31. It is manufactured by Translational Mri, LLC. The 510(k) number is K211059.

When was CereFlow™ V1.2 approved by the FDA?

CereFlow™ V1.2 received FDA 510(k) clearance on 2023-03-31, under approval number K211059.

What company makes CereFlow™ V1.2?

CereFlow™ V1.2 is manufactured by Translational Mri, LLC.

What is the FDA product code for CereFlow™ V1.2?

The FDA product code for CereFlow™ V1.2 is LLZ.

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.